Image

Rare Glycogen Storage Diseases Natural History Study

Rare Glycogen Storage Diseases Natural History Study

Recruiting
90 years and younger
All
Phase N/A

Powered by AI

Overview

The purpose of this study is to collect and study key medical data about several ultra-rare GSDs (Glycogen Storage Diseases) including, but not limited to, GSD types 0a, 0b, VII, X, XII, XIII, XV, PRKAG2 syndrome and Danon disease.

Description

The immediate goal of this research is to create a natural history database to collect information from individuals who have a rare GSD. A repository of clinical, laboratory, and biochemical information on individuals with a rare GSD will allow a more definitive description of the different subtypes to be developed, which will permit development of treatment strategies in the future.

Duke will be the only site where this study takes place. However, since these are rare disorders, participants who receive care at other institutions will be included. The investigators will collect retrospective data from patient charts on diagnosed individuals, as far back as necessary to capture the clinical course of their disorder. Prospective data collected from patient charts after enrollment will be captured as well. Participant's medical records will be continually reviewed for the duration of the study.

Data will be collected from medical records and will only pertain to clinically relevant information, including, but not limited to: demographic and diagnostic information, tissue biopsy results, medical and family history, review of systems, imaging studies, results of liver, muscle, and nerve function testing, and urine and blood laboratory results.

Eligibility

Inclusion Criteria:

  • Diagnosis of a rare GSD, including 0a, 0b, VII, X, XII, XIII, XV, PRKAG2 syndrome or Danon disease
    • Two variants in the gene associated with the specific GSD type (for autosomal recessive diseases)
    • One variant in the gene associated with the specific GSD type (for autosomal dominant or X-linked diseases)
    • Deficient enzyme activity in liver, muscle, skin fibroblast or other tissue
    • One variant in causative gene with evidence of disease, per a clinician
    • Histology as confirmed by a clinician
  • Able to provide informed consent for self (adults) or affected individual (minor or

    adults with a legally authorized representative)

  • Able to provide consent for release of medical records
  • Pregnant women with a diagnosis of a rare GSD will be included

Exclusion Criteria:

  • Unable to provide informed consent for participation for one's self or by legally authorized representative/legal guardian/parent

Study details
    Glycogen Storage Disease
    GSD Type 0A
    GSD Type 0B
    GSD VII
    Tarui Disease
    GSD X
    GSD XII
    GSD XIII
    GSD XV
    PGBM2
    PRKAG2
    Danon Disease
    Polyglucosan Body Myopathy Type 1
    Polyglucosan Body Myopathy Type 2
    RBCK1 Deficiency

NCT06795152

Duke University

15 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.